Thirteen women who were scheduled for hysterectomy volunteered for the study. Nine
women had a levonorgestrel‐releasing intrauterine contraceptive device inserted between …

This manuscript serves as a review of Mirena®, the levonorgestrel intrauterine system (LNG
IUS) as a very successful drug delivery system. The LNG IUS has a very high contraceptive …

The field of controlled release has contributed significantly to female reproductive health and
in particular the prevention of unintended pregnancy. For at least 50 years, there have been …

The ovarian function of 20 healthy users of a levonorgestrel-releasing intrauterine device
was studied by measurements of plasma estradiol, progesterone, and levonorgestrel …

Plasma concentrations of levonorgestrel, progesterone, estradiol, FSH and LH were
measured in seven volunteers who had a levonorgestrel-releasing IUD inserted …

BACKGROUND: The levonorgestrel-releasing intrauterine system (LNG-IUS) is a
contraceptive method approved for five years of use. However, there is some evidence that …

Two levonorgestrel-releasing intrauterine devices (IUD) with different release rates of
levonorgestrel and a'Nova-T'copper-releasing device were compared in a randomised …

Patterns of bleeding and plasma concentrations of levonorgestrel, progesterone, estradiol,
LH and FSH were studied in ten volunteers who had a levonorgestrel-releasing IUD inserted …

The conception rate and outcome of pregnancy of twenty-one women who had been using a
levonorgestrel-releasing intrauterine contraceptive device and who had had the device …

Clinical experience with seventy-two first insertions of a d-norgestrel-releasing IUD is
reported. Plasma d-norgestrel concentrations were measured in twelve subjects. No …